Paras Healthcare IPO
· Hospital & Healthcare Services
IPO Opportunity Score
53/100
Average Opportunity
Apply?
Selective Apply
Risk
Moderate
Est. listing gain
10–15%
Retail allotment odds
—
HNI allotment odds
—
Mixed signals — selective apply only if thesis fits your risk appetite. Prefer 1 lot to limit capital blocked.
Retail and HNI allotment odds are illustrative (often using total subscription as a proxy when category-wise data is unavailable).
Price band
₹660 – ₹693
GMP
+₹95 (+13.71%)
Est. listing
₹788
Issue size
₹1,450 Cr
Subscription
—
Min. investment
₹14,553
GMP last updated: 16-Oct 23:37
IPO DNA
A multi-dimensional read instead of a single number. 2 of 8 dimensions can be assessed from the data we receive — the rest are shown as gaps rather than filled with placeholder scores.
Relative strengths
Liquidity
Relative weaknesses
None of the measurable dimensions score below 50.
Business Quality
No dataCompany financials (revenue, profit, ROE/ROCE, debt) are not part of the IPO feed we consume.
Growth
No dataCompany financials (revenue, profit, ROE/ROCE, debt) are not part of the IPO feed we consume.
Financial Strength
No dataCompany financials (revenue, profit, ROE/ROCE, debt) are not part of the IPO feed we consume.
Valuation
No dataValuation multiples and peer comparables are not available from our current data sources.
Demand
No dataSubscription data has not been published for this issue yet.
Listing Setup
65/100Derived from an unofficial grey-market premium of 13.71%. Last updated 16-Oct 23:37. GMP is unregulated and can reverse quickly.
Governance
No dataPromoter holding, pledge and anchor-investor data are not available from our current data sources.
Liquidity
78/100Structural read from a ₹1,450 Cr issue. Mainboard listings usually see broader participation. This reflects issue structure, not observed post-listing volume.
Dimensions are analytical views built from published issue data and unofficial grey-market quotes. They are not a recommendation to apply for or avoid this IPO.
GMP Divergence Check
Cross-checks the unofficial grey-market premium against visible demand and issue structure, so a strong premium is not read in isolation.
No divergence detected
Not enough published data to run a full cross-check
Subscription not published
Subscription figures are not available yet, so demand could not be cross-checked against the premium.
Checks we could not run
- Valuation vs peers — multiples and comparables are not in our data sources.
- Institutional (QIB) demand quality — category-wise subscription is not published in our feed.
- Anchor-investor participation — not available from our data sources.
Grey-market premium is unofficial and unregulated. This check describes signal consistency only and is not investment advice.
Information Confidence
How complete and fresh the information behind this page is — kept separate from any view on the IPO itself, so a well-documented issue is never confused with an attractive one.
Grey-market premium last updated 16-Oct 23:37.
Published (9)
Price band · Lot size · Issue size · Bidding dates · Listing date · Allotment date · Registrar details · RHP document · Company profile
Awaiting disclosure (1)
Subscription figures
Not collected by this site
- Company financials — revenue, profit, ROE/ROCE, debt
- Valuation multiples and peer comparables
- Category-wise subscription (QIB / NII / Retail / Employee)
- Anchor investors and promoter holding
- Fresh issue vs offer-for-sale split
Sources
- officialExchange / issuer feed (price band, dates, lot size, documents)
- unofficialGrey-market aggregator (premium only)
Scenario Lab
Test this issue against your own assumptions. Every output here is a scenario you control, not a forecast of what will happen.
Break-even price
₹700
1.01% above issue price
Capital deployed
₹14,553
21 shares
Costs recovered
₹146
Both legs of the trade
Tax assumption
20%
Applied to gains above break-even
Cost and tax inputs are yours to set — we do not apply a default brokerage plan or assume your tax slab. Confirm actual charges with your broker and tax treatment with a qualified professional. Scenarios are illustrative and not predictions.
About the company
Issue details
Timeline
Registrar
MUFG Intime India Private Limited
Contact: Shanti Gopalkrishnan
Phone: +91 810 811 4949
parashealthcare.ipo@in.mpms.mufg.comVisit registrar website →Documents
IPO data from Upstox; GMP from unofficial grey-market aggregators. GMP is not regulated and does not guarantee listing performance. Scorecard uses GMP + subscription heuristics — not investment advice.
About Paras Healthcare IPO IPO
IPO detail with price band, GMP, scorecard, subscription heat, timeline and registrar links.
How it works
Review the opportunity score and documents (RHP/DRHP), then use allotment or GMP calculators.
Practical tips
Note allotment and listing dates on your calendar before you apply.
Important to know
GMP and scores are informational — not apply advice.
Related tools
Frequently Asked Questions
- What details are shown for Paras Healthcare IPO?
- Company summary, price band, timeline, lot size, and grey-market premium (GMP) when the data source provides them.
- What is GMP and should I trust it?
- GMP is an unofficial grey-market indication of listing sentiment. It can reverse quickly and is not a guarantee of listing gains.
- Can I apply for the IPO on EnrichReturns?
- No. Apply via ASBA through your bank or broker UPI flow as per the exchange process.
- Where should I read official risk disclosures?
- Always read the Red Herring Prospectus (RHP) and exchange filings. This page is informational, not investment advice.
- How fresh is subscription and GMP data?
- Figures depend on upstream feeds and may lag. Confirm live subscription on NSE/BSE and treat GMP as speculative.
- Is SME different from mainboard?
- Yes. SME IPOs have different lot sizes, eligibility, and liquidity profiles. Check the issue type before applying.